Literature DB >> 23010873

NLRP3 promotes inflammation-induced skin cancer but is dispensable for asbestos-induced mesothelioma.

Melvyn T Chow1, Jürg Tschopp, Andreas Möller, Mark J Smyth.   

Abstract

Asbestos exposure can result in serious and frequently lethal diseases, including malignant mesothelioma. The host sensor for asbestos-induced inflammation is the NLRP3 inflammasome and it is widely assumed that this complex is essential for asbestos-induced cancers. Here, we report that acute interleukin-1β production and recruitment of immune cells into peritoneal cavity were significantly decreased in the NLRP3-deficient mice after the administration of asbestos. However, NLRP3-deficient mice displayed a similar incidence of malignant mesothelioma and survival times as wild-type mice. Thus, early inflammatory reactions triggered by asbestos are NLRP3-dependent, but NLRP3 is not critical in the chronic development of asbestos-induced mesothelioma. Notably, in a two-stage carcinogenesis-induced papilloma model, NLRP3-deficient mice showed a resistance phenotype in two different strain backgrounds, suggesting a tumour-promoting role of NLRP3 in certain chemically-induced cancer types.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23010873     DOI: 10.1038/icb.2012.46

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  29 in total

1.  Inflammasome Activity in Non-Microbial Lung Inflammation.

Authors:  Jennifer L Ather; Rebecca A Martin; Karina Ckless; Matthew E Poynter
Journal:  J Environ Immunol Toxicol       Date:  2014-09-20

Review 2.  NLRP3 inflammasome in cancer and metabolic diseases.

Authors:  Bhesh Raj Sharma; Thirumala-Devi Kanneganti
Journal:  Nat Immunol       Date:  2021-03-11       Impact factor: 25.606

Review 3.  Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans.

Authors:  Eileen D Kuempel; Marie-Claude Jaurand; Peter Møller; Yasuo Morimoto; Norihiro Kobayashi; Kent E Pinkerton; Linda M Sargent; Roel C H Vermeulen; Bice Fubini; Agnes B Kane
Journal:  Crit Rev Toxicol       Date:  2016-08-18       Impact factor: 5.635

Review 4.  Inflammasomes: Their Role in Normal and Complicated Pregnancies.

Authors:  Nardhy Gomez-Lopez; Kenichiro Motomura; Derek Miller; Valeria Garcia-Flores; Jose Galaz; Roberto Romero
Journal:  J Immunol       Date:  2019-12-01       Impact factor: 5.422

5.  Genetic variants of BIRC3 and NRG1 in the NLRP3 inflammasome pathway are associated with non-small cell lung cancer survival.

Authors:  Dongfang Tang; Hongliang Liu; Yuchen Zhao; Danwen Qian; Sheng Luo; Edward F Patz; Li Su; Sipeng Shen; David C ChristianI; Wen Gao; Qingyi Wei
Journal:  Am J Cancer Res       Date:  2020-08-01       Impact factor: 6.166

6.  Asbestos-Induced Mesothelial to Fibroblastic Transition Is Modulated by the Inflammasome.

Authors:  Joyce K Thompson; Maximilian B MacPherson; Stacie L Beuschel; Arti Shukla
Journal:  Am J Pathol       Date:  2017-01-03       Impact factor: 4.307

7.  Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.

Authors:  Paul A Beavis; Upulie Divisekera; Christophe Paget; Melvyn T Chow; Liza B John; Christel Devaud; Karen Dwyer; John Stagg; Mark J Smyth; Phillip K Darcy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-20       Impact factor: 11.205

Review 8.  Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies.

Authors:  Angela Bononi; Andrea Napolitano; Harvey I Pass; Haining Yang; Michele Carbone
Journal:  Expert Rev Respir Med       Date:  2015-08-26       Impact factor: 3.772

9.  Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma.

Authors:  Yuwaraj Kadariya; Craig W Menges; Jacqueline Talarchek; Kathy Q Cai; Andres J Klein-Szanto; Ralph A Pietrofesa; Melpo Christofidou-Solomidou; Mitchell Cheung; Brooke T Mossman; Arti Shukla; Joseph R Testa
Journal:  Cancer Prev Res (Phila)       Date:  2016-03-02

Review 10.  Signal-transducing innate receptors in tumor immunity.

Authors:  Sho Hangai; Yoshitaka Kimura; Tadatsugu Taniguchi; Hideyuki Yanai
Journal:  Cancer Sci       Date:  2021-05-01       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.